CME Group downgraded to Underperform from Market Perform at Keefe Bruyette Keefe Bruyette downgraded CME Group to Underperform after lowering its 2013 exchange volume assumptions. The firm dropped its price target for shares to $47 from $57.
News For CME From The Last 14 Days
Check below for free stories on CME the last two weeks.
CME sued on claims high-frequency traders purchased access, Bloomberg says CME Group is facing a lawsuit by by three of its users who claim the company sold access to order information to high-frequency traders ahead of other market participants, according to Bloomberg, citing a complaint filed in Chicago federal court. Reference Link